Several similar drugs have had similar early results and then failed in more comprehensive trials. Hopefully this time it'll be different, but I think if you po

Several similar drugs have had similar early results and then failed in more comprehensive trials. Hopefully this time it'll be different, but I think if you polled people in the industry, most would wager that it won't be. There is a large phase 3 trial going on now https://www.clinicaltrials.gov/ct2/show/NCT02477800 https://www.clinicaltrials.gov/ct2/show/NCT02477800 but we won't know the results for several years. They are still recruiting patients, so if you or someone you know has early stage Alzheimer's, it's worth considering.